Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2018-04-18
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.45+1,000700,8420%+$1,450
D
2018-04-17
COOLPolarityte, Inc.Dyer Jeffrey HansenDirP - Purchase$16.57+3,00026,522+13%+$49,710
DM
2018-04-17
ONCESpark Therapeutics, Inc.Furey JohnCOOS - Sale+OE$82.52-13,2770-100%-$1,095,683
2018-04-16
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$37.56-5,000152,283-3%-$187,797
D
2018-04-16
SGMOSangamo Therapeutics, IncYi KathySVP, CFOS - Sale+OE$19.83-5,0007,250-41%-$99,144
D
2018-04-13
SGMOSangamo Therapeutics, IncHerberts Curt A. IIISr.VP, Chief Business OfficerS - Sale+OE$20.00-8,16314,625-36%-$163,260
2018-04-16
CVMCel Sci CorpYoung Peter RDirP - Purchase$1.80+6,5007,691+546%+$11,675
2018-04-12
AMGNAmgen IncHarper Sean EEVP, Research, DevelopmentS - Sale$172.68-1,52556,788-3%-$263,337
D
2018-04-13
GILDGilead Sciences IncCogan John FrancisDirS - Sale+OE$75.56-5,83352,619-10%-$440,741
D
2018-04-12
ONCESpark Therapeutics, Inc.Furey JohnCOOS - Sale+OE$77.51-20,0000-100%-$1,550,200
2017-10-12
ONCESpark Therapeutics, Inc.Sigal ElliotDirP - Purchase$90.75+2911,2140%+$2,632
2017-11-28
ONCESpark Therapeutics, Inc.Sigal ElliotDirS - Sale$72.43-2911,2140%-$2,100
D
2018-04-12
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$180.17-3,00024,905-11%-$540,508
D
2018-04-12
MATNMateon Therapeutics IncReynolds Donald RogersDirP - Purchase$0.00+250,000280,000+833%+$0
D
2018-04-12
MATNMateon Therapeutics IncSchwieterman William DPres, CEOP - Purchase$0.00+625,000625,747>999%+$0
D
2018-04-12
MATNMateon Therapeutics IncLoar Matthew MCFOP - Purchase$0.00+250,000300,000+500%+$0
D
2018-04-11
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$39.00-10,0001,141-90%-$390,000
D
2018-04-12
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$20.00-7,71421,664-26%-$154,280
M
2018-04-11
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$41.87-8,8001,010,291-1%-$368,472
D
2018-04-10
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale+OE$19.00-43,334603,204-7%-$823,346
D
2018-03-21
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$19.00-3,39917,777-16%-$64,581
D
2018-04-10
MNTAMomenta Pharmaceuticals IncStoner ElizabethDirS - Sale+OE$19.00-3,39919,378-15%-$64,581
DM
2018-04-10
CBMGCellular Biomedicine Group, Inc.Liu Wen TaoDirS - Sale+OE$20.09-22,444213,076-10%-$450,832
2018-04-10
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$18.38-2,4510-100%-$45,049
D
2018-04-09
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$50.52-18,832687,146-3%-$951,393
D
2018-04-09
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$34.00-10,0001,141-90%-$340,000
D
2018-04-06
SGMOSangamo Therapeutics, IncConner Edward R.SVP, Chief Medical OfficerS - Sale+OE$17.41-5,0008,125-38%-$87,065
D
2018-04-06
GILDGilead Sciences IncCogan John FrancisDirS - Sale+OE$74.47-5,83352,619-10%-$434,384
D
2018-04-04
WINTWindtree Therapeutics Inc /de/Lee'S Pharmaceutical Holdings Ltd10%P - Purchase$4.80+541,6672,853,271+23%+$2,600,002
D
2018-04-02
BOLDAudentes Therapeutics, Inc.Patterson Matthew RPres, CEOS - Sale+OE$30.01-700171,8140%-$21,009
D
2018-04-02
GILDGilead Sciences IncMartin John CDirS - Sale+OE$73.14-50,0003,017,762-2%-$3,656,806
D
2018-04-02
EIGREiger Biopharmaceuticals, Inc.Quan JoanneChief Medical OfficerS - Sale+OE$10.00-4,0000-100%-$40,000
2018-04-02
AVXSAvexis, Inc.Kaspar Brian K.Chief Scientific OfficerS - Sale$119.50-15,0001,755,602-1%-$1,792,440
D
2018-04-02
AVXSAvexis, Inc.Knudten Andrew F.SrVP, Manufacture, Supply ChaiS - Sale+OE$119.49-2,0008,800-19%-$238,982
D
2018-04-02
AVXSAvexis, Inc.Litalien James JSrVP, Chief Reg, Quality OfficS - Sale+OE$119.44-5,0003,800-57%-$597,213
D
2018-04-02
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$168.72-2,25029,272-7%-$379,608
D
2018-04-02
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$167.52-22,00024,905-47%-$3,685,387
2018-04-03
XLRNAcceleron Pharma IncRovaldi ChristopherSVP, Program Mgmt, OpsS - Sale$38.40-3,50025,858-12%-$134,395
2018-04-03
XLRNAcceleron Pharma IncKumar RavindraSVP, Chief Scientific OfficerS - Sale$38.41-1,20395,935-1%-$46,205
2018-04-03
XLRNAcceleron Pharma IncSherman Matthew LEVP, Chief Medical OfficerS - Sale$38.43-4,60077,267-6%-$176,772
2018-04-03
XLRNAcceleron Pharma IncMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$38.45-4,00043,939-8%-$153,792
D
2018-04-02
GILDGilead Sciences IncCogan John FrancisDirS - Sale+OE$74.93-5,83352,619-10%-$437,067
D
2018-04-02
SGMOSangamo Therapeutics, IncMento Steven JDirS - Sale+OE$18.40-7,21544,046-14%-$132,758
D
2018-04-02
SGMOSangamo Therapeutics, IncHerberts Curt A. IIISr.VP, Chief Business OfficerS - Sale+OE$18.30-2,27814,625-13%-$41,684
2018-04-02
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$32.16-8,3331,310,298-1%-$267,969
A
2018-03-27
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$38.40-200206,4780%-$7,680
2018-03-29
ATRAAtara Biotherapeutics, Inc.Clark Mitchall G.EVP, Chief R, QA OfficerS - Sale$40.07-22,400133,671-14%-$897,568
D
2018-03-15
BOLDAudentes Therapeutics, Inc.Newman MarySVP, Regulatory AffairsS - Sale+OE$30.36-10,0000-100%-$303,627
D
2017-03-29
BOLDAudentes Therapeutics, Inc.Prasad SuyashSVP, Chief Med OfficerS - Sale+OE$30.02-7,8000-100%-$234,195
M
2018-03-27
ADAPAdaptimmune Therapeutics PlcThompson Peter A.DirS - Sale$11.50-1,048,0675,101,310-17%-$12,053,730
M
2018-03-27
ADAPAdaptimmune Therapeutics PlcOrbimed Advisors LLCDirS - Sale$11.50-1,048,0675,101,310-17%-$12,053,730
M
2018-03-08
FENCFennec Pharmaceuticals Inc.Manchester Management Pr, LLC10%S - Sale$10.61-914,7452,916,666-24%-$9,704,023
M
2017-02-28
FENCFennec Pharmaceuticals Inc.Manchester Management Pr, LLC10%P - Purchase$7.28+79,8302,323,463+4%+$581,310
M
2017-04-12
FENCFennec Pharmaceuticals Inc.Manchester Management Pr, LLC10%S - Sale$9.22-70,1002,323,463-3%-$646,577
M
2016-08-23
FENCFennec Pharmaceuticals Inc.Manchester Management Pr, LLC10%P - Purchase$2.01+96,0003,795,681+3%+$192,640
M
2016-01-27
FENCFennec Pharmaceuticals Inc.Manchester Management Pr, LLC10%P - Purchase$2.06+190,8504,059,013+5%+$392,528
M
2015-12-29
FENCFennec Pharmaceuticals Inc.Manchester Management Co LLC10%P - Purchase$1.78+40,6003,508,831+1%+$72,304
M
2015-05-27
FENCFennec Pharmaceuticals Inc.Manchester Management Co LLC10%P - Purchase$1.65+102,9603,468,231+3%+$170,046
M
2014-12-24
FENCFennec Pharmaceuticals Inc.Manchester Management Co LLC10%P - Purchase$2.51+189,8003,365,271+6%+$475,668
M
2014-08-29
FENCFennec Pharmaceuticals Inc.Manchester Management Co LLC10%P - Purchase$2.48+82,6663,534,803+2%+$205,132
DM
2018-03-26
BOLDAudentes Therapeutics, Inc.Prasad SuyashSVP, Chief Med OfficerS - Sale+OE$30.00-2,2000-100%-$66,000
2018-03-26
BOLDAudentes Therapeutics, Inc.Lange Louis GDirS - Sale$28.89-48,000505,974-9%-$1,386,937
D
2018-03-27
ATRAAtara Biotherapeutics, Inc.Clark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$37.87-100,203156,071-39%-$3,795,062
M
2018-03-26
CSBRChampions Oncology, Inc.Morris RonnieCEOP - Purchase$3.59+4,5351,116,5820%+$16,298
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcViswanathan Ravi10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcSonsini Peter W.10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcSandell Scott D10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcMott David MDir, 10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcKerins Patrick J10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcFlorence Anthony A. Jr.10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcBaskett Forest10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcBarris Peter J10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcBarrett M James10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
M
2018-03-26
ADAPAdaptimmune Therapeutics PlcNew Enterprise Associates 14, L.P.10%P - Purchase$1.92+6,571,16479,978,672+9%+$12,587,753
D
2018-03-26
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.Pres, CEOP - Purchase$1.76+2,83981,541+4%+$4,997
2018-03-26
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$30.00-5,000157,283-3%-$150,000
M
2018-03-26
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$38.59-8,8001,225,769-1%-$339,549
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Viswanathan Ravi10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Sonsini Peter W.10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Sandell Scott D10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Mott David M10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Kerins Patrick J10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Florence Anthony A. Jr.10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Baskett Forest10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Barris Peter J10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.Barrett M James10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
D
2018-03-27
TCONTracon Pharmaceuticals, Inc.New Enterprise Associates 14, L.P.10%P - Purchase$2.70+707,9643,466,003+26%+$1,911,503
2018-03-26
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$39.79-18,327352,905-5%-$729,265
M
2018-03-23
BCDABiocardia, Inc.Stertzer Simon HDirP - Purchase$1.89+18,0003,575,094+1%+$33,960
M
2017-06-29
APHBAmpliphi Biosciences CorpPerry Michael SDirP - Purchase$0.68+292,592411,335+246%+$200,002
DM
2016-06-21
APHBAmpliphi Biosciences CorpCook Jeremy CurnockDirP - Purchase$1.54+354,315411,435+620%+$545,330
D
2018-03-23
GILDGilead Sciences IncCogan John FrancisDirS - Sale+OE$75.02-5,83352,619-10%-$437,588
2018-03-15
LJPCLa Jolla Pharmaceutical CoPerceptive Advisors LLC10%P - Purchase$29.50+700,0004,313,611+19%+$20,650,000
M
2018-03-22
CSBRChampions Oncology, Inc.Morris RonnieCEOP - Purchase$3.50+7001,112,0470%+$2,447
DM
2018-03-22
VYGRVoyager Therapeutics, Inc.Henderson JaneSVP, CFO, Corp. Dev.S - Sale+OE$20.87-31,1000-100%-$649,117
M
2018-03-21
ADAPAdaptimmune Therapeutics PlcViswanathan Ravi10%P - Purchase$1.91+1,268,50873,407,508+2%+$2,417,847
M
2018-03-21
ADAPAdaptimmune Therapeutics PlcSonsini Peter W.10%P - Purchase$1.91+1,268,50873,407,508+2%+$2,417,847
M
2018-03-21
ADAPAdaptimmune Therapeutics PlcSandell Scott D10%P - Purchase$1.91+1,268,50873,407,508+2%+$2,417,847
M
2018-03-21
ADAPAdaptimmune Therapeutics PlcMott David MDir, 10%P - Purchase$1.91+1,268,50873,407,508+2%+$2,417,847
M
2018-03-21
ADAPAdaptimmune Therapeutics PlcKerins Patrick J10%P - Purchase$1.91+1,268,50873,407,508+2%+$2,417,847

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top